|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent DCT insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why DCT insider buys are important for investors to follow.
Date | Insider | Price | Amount |
7-1-2022 Insider Buy |
Eva F. Harris Chief Strategy Officer |
$14.25
CAGR »
|
$50,103.00 3,516 shares |
4-25-2022 Insider Buy |
Kevin R. Rhodes Chief Financial Officer |
$16.66
CAGR »
|
$49,980.00 3,000 shares |
8-14-2020 Insider Buy |
Vincent A. Chippari Chief Financial Officer |
$27.00
CAGR »
|
$54,000.00 2,000 shares |
8-14-2020 Insider Buy |
Kathleen M. Crusco Director |
$27.00
CAGR »
|
$249,750.00 9,250 shares |
8-14-2020 Insider Buy |
Matthew R. Foster Chief Operating Officer |
$27.00
CAGR »
|
$398,250.00 14,750 shares |
8-14-2020 Insider Buy |
Eva F. Huston Chief Strategy Officer |
$27.00
CAGR »
|
$153,900.00 5,700 shares |
8-14-2020 Insider Buy |
Michael A. Jackowski Chief Executive Officer |
$27.00
CAGR »
|
$148,500.00 5,500 shares |
8-14-2020 Insider Buy |
Charles E. Moran Director |
$27.00
CAGR »
|
$356,400.00 13,200 shares |
8-14-2020 Insider Buy |
Stuart Nicoll Director |
$27.00
CAGR »
|
$324,000.00 12,000 shares |
8-14-2020 Insider Buy |
Francis J. Pelzer Director |
$27.00
CAGR »
|
$270,000.00 10,000 shares |
8-24-2011 Insider Buy |
Jeff Phelan Managing Director |
$4.22
CAGR »
|
$248,165.88 58,750 shares |
8-17-2011 Insider Buy |
Jeff Phelan Managing Director |
$4.47
CAGR »
|
$249,682.68 55,800 shares |
6-10-2011 Insider Buy |
Thomas G. Wattles Chairman |
$4.91
CAGR »
|
$98,200.00 20,000 shares |
Also See: Institutional Holders of DCT
Also See: SEC filings
Below we present the annualized performance delivered by DCT stock since 7-1-2022 (the date of the most recent
insider purchase). The performance of the investment from the time DCT insider buying occurred is the ultimate
test of whether insiders were right about DCT being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
07/05/2022 |
|
End date: |
03/30/2023 |
|
Start price/share: |
$16.20 |
|
End price/share: |
$18.99 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
17.22% |
|
Annualized Gain: |
23.46% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$11,722.00 |
|
Years: |
0.73 |
|
DCT Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent DCT insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding DCT
|
|